October 11, 2022
MindAffect selected for Pole Position Programme – DeepTech/Medical field
MindAffect, a BCI/AI Healthtech company specializing in the development of NextGen hearing/vision diagnostic systems, is delighted to have been selected for the Pole Position Programme – a new, exclusive initiative aimed at facilitating the development of deeptech startups to successful scale-ups. The programme will focus on advancing the progress of 10 ambitious deeptech companies within the medical field to reach the scaleup growth phase by providing tailored scaling knowledge from experts, and facilitating peer-to-peer learning between participants.
Jennifer Goodall, CEO MindAffect: “We are extremely pleased to have been selected for such an exciting and prestigious program. We view it as a terrific opportunity to learn from our peers and eco-system experts to facilitate the transformation of our proprietary technology into the successful launch of groundbreaking diagnostic systems. We look forward to an inspiring and dynamic experience.”
Bert-Arjan Millenaar, CEO Founder NLC (MindAffect’s Venture Builder): “We are delighted that MindAffect has been chosen for the Pole Position Programme – they join an elite group of NLC Ventures who have greatly benefited from the programme.”
Pole Position – advancing DeepTech stars to the front of the Race
While Dutch incubators provide support for deeptech companies in their early growth stages, only a few initiatives in the Netherlands focus on supporting and facilitating the successful transition of deeptech startups into a scaleup phase. This is why Techleap.nl, together with four incubators: YES! Delft, UtrechtInc Braventure, and NovelT, have joined forces under one national deeptech-specific initiative: Pole Position. Pole Position is structured to provide a dynamic peer-to-peer learning environment for a selected group of 10 early-stage deeptech ventures to manage growth challenges successfully. These Healthtech-based sessions will be led by experienced entrepreneurs and structured in 3 Phases: Insight, Focus and Action. The programme will provide a strong network of key stakeholders, including policymakers and investors, to allow the companies to scale faster and more efficiently.
MindAffect, a HealthTech Venture spun out of the Donders Institute at Radboud University in Nijmegen, is specialized in the application of BCI, AI and neuroscience to enhance neural circuit testing and human communication. MindAffect’s activities originated with the development of a brain response-based communication system for locked-in ALS patients. MindAffect has expanded its expertise to develop purely brain response-based diagnostic systems. MindAffect is currently working with leading medical and corporate partners to develop the next generation of Vision, Hearing and Brain Health diagnostic systems. In 2021, MindAffect raised its Series A financing from Oost NL, NLC Ventures and MSB Isala. For more information please visit www.mindaffect.nl.